TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$4.73
-0.02 (-0.42%)
As of Jun 21, 10:14 PM ET ·
Financial Highlights (FY 2026)
Revenue
107.60M
Net Income
-286,491,642
Gross Margin
29.3%
Profit Margin
-266.3%
Rev Growth
+9.3%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 29.3% 29.3% 58.9% 58.9%
Operating Margin -277.9% -250.1% 36.6% 37.4%
Profit Margin -266.3% -252.9% 27.4% 25.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 107.60M 98.41M 180.40M 169.99M
Gross Profit 31.52M 28.83M 106.25M 100.12M
Operating Income -299,066,462 -246,167,748 66.09M 63.51M
Net Income -286,491,642 -235,817,155 49.45M 42.44M
Gross Margin 29.3% 29.3% 58.9% 58.9%
Operating Margin -277.9% -250.1% 36.6% 37.4%
Profit Margin -266.3% -252.9% 27.4% 25.0%
Rev Growth +9.3% +9.3% -1.4% +19.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 47.20M 47.20M 368.43M 383.92M
Total Equity 235.66M 235.66M 614.67M 608.97M
D/E Ratio 0.20 0.20 0.60 0.63
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -287,459,795 -249,759,287 94.91M 94.57M
Free Cash Flow 60.57M 46.11M